| Literature DB >> 26217796 |
Yi-Chao Lee1, Jun-Wei Lee2, Chi-Chen Huang1, Ming-Heng Wu3, Kuen-Haur Lee4.
Abstract
The data in this article is related to the research article entitled, "Targeting of Multiple Oncogenic Signaling Pathways by Hsp90 Inhibitor Alone or in Combination with Berberine for Treatment of Colorectal Cancer" [1]. Overexpression of survivin induces resistance to various anticancer therapies such as chemotherapy and radiation therapy in colorectal cancer (CRC) cells. To determine significant correlations of biological functions/pathways with survivin, 4567 significant genes were analyzed from the GEO DataSet (GSE21815) of CRC and these were overlaid onto a global molecular network developed from information contained in the Ingenuity Pathway Analysis (IPA) database. The data here present the most significant disease and disordered biological functions, significant molecular/cellular functions and significant categories in physiological development/system functions which were associated with CRC. The top 10 canonical signaling pathways associated with CRC were categorize in order based on the level of statistical significance.Entities:
Year: 2015 PMID: 26217796 PMCID: PMC4510466 DOI: 10.1016/j.dib.2015.05.017
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Biological functions associated with CRC.
| 1 | Cancer | 2.09E−13 to 2.16E−03 | 1795 |
| 2 | Infectious diseases | 1.50E−22 to 1.50E−05 | 754 |
| 3 | Renal and urological diseases | 8.10E−18 to 8.01E−05 | 228 |
| 4 | Organismal injury and abnormalities | 1.62E−18 to 1.62E−18 | 164 |
| 5 | Dermatological diseases and conditions | 4.43E−18 to 4.43E−18 | 163 |
| 1 | Cell death and survival | 7.64E−18 to 2.46E−03 | 1427 |
| 2 | Gene expression | 2.37E−20 to 2.51E−04 | 1013 |
| 3 | Cell cycle | 2.82E−22 to 2.57E−03 | 801 |
| 4 | DNA replication, recombination, and repair | 8.36E−23 to 2.46E−03 | 648 |
| 5 | RNA post-transcriptional modifications | 1.22E−37 to 9.81E−04 | 214 |
| 1 | Connective tissue development and functions | 2.64E−10 to 2.46E−03 | 333 |
| 2 | Embryonic development | 3.37E−12 to 1.73E−03 | 323 |
| 3 | Tissue morphology | 8.40E−07 to 2.39E−03 | 255 |
| 4 | Organismal development | 2.27E−07 to 1.73E−03 | 220 |
| 5 | Tissue development | 6.03E−08 to 2.07E−03 | 119 |
Top 10 significantly changed canonical signaling pathways between CRC patients and normal controls.
| EIF2 signaling | 3.03E01 |
| Protein ubiquitination pathway | 2.38E01 |
| Regulation of eIF4 and p70S6K signaling | 1.64E01 |
| Hereditary breast cancer signaling | 1.19E01 |
| Role of BRCA1 in DNA damage response | 1.16E01 |
| Mitotic roles of polo-like kinase | 1.13E01 |
| tRNA charging | 1E01 |
| mTOR signaling | 9.18E00 |
| Cell cycle control of chromosomal replication | 9.02E00 |
| Role of CHK proteins in cell cycle checkpoint control | 8.09E00 |
| Subject area | Medicine, biology |
|---|---|
| More specific subject area | Molecular biology, Cancer biology |
| Type of data | Table |
| How data was acquired | Microarray data were obtained from the Gene Expression Omnibus (GEO) repository at the NCBI were analyzed using the Ingenuity pathway analysis (IPA) database |
| Data format | Analyzed |
| Experimental factors | None |
| Experimental features | Gene expression data of 132 samples of laser microdissected CRC tumors and nine normal colon controls were retrieved from the GEO DataSet under the accession number GSE21815 and imported into the IPA Tool to determine significant correlations of biological functions/pathways with survivin |
| Data source location | Taipei, Taiwan |
| Data accessibility | The data are supplied with this article |